Erratum: Corrigendum: Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis

Scientific Reports 6: Article number: 21005; published online: 15 February 2016; updated: 02 September 2016

In this Article, Affiliation 4 is incomplete. The correct affiliation is listed below:

Department of Virology and Immunology, Cancer Biology Department, National Cancer Institute, Cairo University, Children’s Cancer Hospital Egypt 57357, Cairo 11712, Egypt.

Additional information

The online version of the original article can be found at 10.1038/srep21005

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hammam, O., Elkhafif, N., Attia, Y. et al. Erratum: Corrigendum: Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis. Sci Rep 6, 32052 (2016). https://doi.org/10.1038/srep32052

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.